The Pitch avatar

Dexa/The Pitch

Learn more
Published Oct 30, 2024

#149 Dopl

Explore Ryan James' innovative approach to bridging healthcare disparities in rural America with telerobotic systems, featuring groundbreaking remote ultrasound capabilities, and witness investors as they navigate the complexities and opportunities of healthcare investment.
Episode Highlights
The Pitch logo

Topics covered

Popular Clips

Questions from this episode

Episode Highlights

  • Disparities

    , CEO of Doppel Technologies, highlights the stark healthcare disparities faced by rural communities. He explains that rural patients often suffer from delayed or inaccessible care due to the concentration of specialists in urban areas. To address this, Doppel aims to democratize healthcare access through innovative telerobotic systems.

    Our mission is equal access to healthcare. Did you know that if you live in a rural area, you're more likely to die from all top 10 causes of death?

    ---

    By leveraging technology, Ryan seeks to dismantle ineffective systems and rebuild them to support everyone, regardless of location 1.

       

    Innovation

    Doppel's approach to rural healthcare innovation involves deploying $60,000 telerobotic ultrasound systems in rural hospitals, with Medicare covering significant costs. notes that these systems can perform procedures remotely, reducing the need for patients to travel long distances. This model not only addresses healthcare access but also provides economic viability for rural hospitals.

    We're planning to sell the system for 60k and then charge a 50 to $100 per procedure fee. And so we really start to see economic success with volume of procedure.

    ---

    The potential for franchise opportunities and mobile applications further expands the reach of this technology 2.

       

    Vision

    Doppel's vision extends beyond ultrasound, aiming to revolutionize minimally invasive procedures through telerobotics. shares that their system is built on an off-the-shelf robot, making it versatile across various medical and non-medical applications. The company is poised to be first to market in the US, with plans for FDA clearance by demonstrating equivalence to existing systems.

    Our ultimate vision is to perform these procedures autonomously.

    ---

    This strategic positioning not only opens up a significant market opportunity but also sets the stage for future advancements in healthcare technology 3.

Related Episodes